de Souza Carvalho G, Cunha de Sousa Martins CL, Wang K, Farwell MD, Salama AKS Beyond Routine Surveillance Imaging for Melanoma: Emerging Technologies for Detecting Early Recurrence and Guiding Clinical Management. , Am Soc Clin Oncol Educ Book., 46(3): 2026,e520544
Postow MA, Zang PD, Pal SK, Mauguen A, Farwell M, Gordon M, Hays D, Wong JYC, Chen D, Ulaner GA, Esposito G, McConathy J, Graham MM, Shields AF, Van den Abbeele AD, Butler MO, Thomas JS, Twardowski P, Narang J, Singh AP, Dey A, Maresca KP, Keliher E, Liu F, Potdevin G, Schmidt G, Le W, Wilson I, Mascioni A, Jia F, Korn R, Ferris MR, Schmiedehausen K, Pandit-Taskar N, Margolin KA CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study. , J Immunother Cancer., 14(3): 2026,e012208
Babazada H, Martorano P, Lee H, Geng S, Batra V, Maris JM, Pryma DA, Gitto SB, Farwell MD PARP1-targeted alpha therapy enhances target expression. , EJNMMI Res., 15(1): 2025,63
Sarkar S, Pham JM, Edwards KJ, Sharma N, Xu K, King AP, Del Castillo AF, Farwell MD, Pryma DA, Schuster SJ, Sellmyer MA A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points. , EJNMMI Res., 15(1): 2025,26
Gupta PK, Li LZ, Singh DK, Nova S, Arias-Mendoza F, Orlovskiy S, Chawla S, Nelson DS, Farwell MD, Nath K MRS and Optical Imaging Studies of Therapeutic Response to Combination Therapy Targeting BRAF/MEK in Murine Melanomas. , Acad Radiol., S1076-6332(25)00090-X: 2025,Epub ahead of print
Weeks JK, Pantel AR, Gitto SB, Liu F, Schubert EK, Pryma DA, Farwell MD, Mankoff DA, Mach RH, Simpkins F, Lin LL [18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status. , J Nucl Med., 66(1): 2025,34-39
Young AJ, Pantel AR, Kiani M, Doot RK, Bagheri S, Pryma DA, Farwell MD, Li S, Lee H, Schubert EK, Secreto A, Zuckerman SP, Nayak A, Choi H, Carlin S, DeMichele A, Mankoff DA, Zhou R, Mach RH, McDonald ES Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted 18F-Fluorthanatrace PET in Breast Cancer. , J Nucl Med., 65(12): 2024,1862-1868
Wang K, Coutifaris P, Brocks D, Wang G, Azar T, Solis S, Nandi A, Anderson S, Han N, Manne S, Kiner E, Sachar C, Lucas M, George S, Yan PK, Kier MW, Laughlin AI, Kothari S, Giles J, Mathew D, Ghinnagow R, Alanio C, Flowers A, Xu W, Tenney DJ, Xu X, Amaravadi RK, Karakousis GC, Schuchter LM, Buggert M, Oldridge D, Minn AJ, Blank C, Weber JS, Mitchell TC, Farwell MD, Herati RS, Huang AC Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells. , Cancer Cell., 42(9): 2024,1582-1597.e10
Vidula MK, Selvaraj S, Rojulpote C, Bhattaru A, Kc W, Hansbury M, Schubert E, Clancy CB, Rossman M, Goldberg LR, Farwell M, Pryma D, Bravo PE Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis. , Circ Cardiovasc Imaging., 17(8): 2024,e016774
Hartmann K, Gillman JA, Lazor JW, Ware JB, Weeks JK, Nasrallah IM, Farwell MD, Pantel AR 68Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis. , Clin Nucl Med., 49(1): 2024,9-15
